Vaxxas Appoints David Hoey as Company’s First CEO

You may also like

12 August 2020

Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia

06 October 2020

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

13 December 2016

OneVentures awarded Biomedical Translation $170M Funding

Announcement, Media Release

05 August 2018

Australian First:-Israeli venture partnership launches new Venture Credit Fund to invest in high-growth technology companies

15 December 2015

OneVentures commits $3M to launch Australian wearable technology innovation for global dementia market

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor
clear Close